Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
11,022
+2,851
+35% +$329K 0.01% 629
2026
Q1
$976K Buy
8,171
+1,031
+14% +$135K 0.01% 672
2025
Q4
$972K Buy
7,140
+232
+3% +$33.4K 0.01% 634
2025
Q3
$1.02M Buy
6,908
+1,362
+25% +$189K 0.01% 597
2025
Q2
$718K Sell
5,546
-2,026
-27% -$245K 0.01% 624
2025
Q1
$905K Buy
7,572
+2,653
+54% +$329K 0.01% 568
2024
Q4
$571K Sell
4,919
-580
-11% -$73.3K 0.01% 575
2024
Q3
$743K Buy
5,499
+590
+12% +$78.9K 0.01% 460
2024
Q2
$666K Buy
4,909
+937
+24% +$127K 0.01% 460
2024
Q1
$513K Buy
3,972
+400
+11% +$48.3K 0.01% 497
2023
Q4
$408K Buy
3,572
+1,313
+58% +$131K 0.01% 514
2023
Q3
$206K Buy
2,259
+259
+13% +$26.7K ﹤0.01% 704
2023
Q2
$225K Buy
+2,000
New +$212K ﹤0.01% 635

Other funds holding XYL

HB Wealth Management's XYL Position: Q2 2026 in Review

HB Wealth Management increased its Xylem (XYL) stake by 35% in Q2 2026, buying an estimated $329K and bringing the position to 11,022 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #629.

HB Wealth Management first reported a position in XYL in Q2 2023 and has held it in 13 quarters since. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • HB Wealth Management held 11,022 shares of Xylem worth $1.3M as of Q2 2026.
  • HB Wealth Management bought 2,851 Xylem shares in Q2 2026, an estimated $329K.
  • Xylem made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #629 holding.
  • HB Wealth Management first reported a position in Xylem in Q2 2023 and has held it in 13 quarters since.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.